{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T04:06:17Z","timestamp":1788667577819,"version":"build-2803163510"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi di Roma La Sapienza"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Tuberculosis (TB) remains a major global health challenge, worsened by the rise of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains. In this study, we employed a combined computational and medicinal chemistry approach to design, synthesize, and evaluate new pyrrole-based analogues of Sudoterb (\n                    <jats:bold>1<\/jats:bold>\n                    , LL-3858) as potential anti-TB agents. Ligand-based quantitative structure\u2013activity relationships (QSAR) and 3-D QSAR models, as well as structure-based docking and COMBINE analyses, were developed and used to analyze the anti-TB structural determinants and investigate the putative targeting to the MmpL3 transporter. Nineteen new analogues, belonging to amide (\n                    <jats:bold>2a\u2013j<\/jats:bold>\n                    ) and carbamate (\n                    <jats:bold>3a\u2013i<\/jats:bold>\n                    ) series, were synthesized and tested against\n                    <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                    H37Rv resistant strain using the microplate Alamar Blue assay. Most of the synthesized analogues showed enhanced potency compared to Sudoterb (MIC\u2009=\u200920.7 \u00b5M), with\n                    <jats:bold>2i<\/jats:bold>\n                    (MIC\u2009=\u20092.8 \u00b5M) and\n                    <jats:bold>3\u00a0h<\/jats:bold>\n                    (MIC\u2009=\u20092.4 \u00b5M) emerging as the most potent and selective derivatives (IC\n                    <jats:sub>50<\/jats:sub>\n                    \u2009&gt;\u200980\u00a0\u00b5M in Vero cells). Computational predictions aligned well with experimental results, validating the modeling workflow. These findings identify\n                    <jats:bold>2i<\/jats:bold>\n                    and\n                    <jats:bold>3\u00a0h<\/jats:bold>\n                    as promising lead compounds and highlight the utility of integrating computational modeling with rational synthesis to accelerate anti-TB drug discovery.\n                  <\/jats:p>","DOI":"10.1007\/s10822-026-00794-6","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T05:21:20Z","timestamp":1775452880000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Combined computational and classical medicinal chemistry procedure to disclose novel pyrrole-based compounds as potential antituberculosis agents"],"prefix":"10.1007","volume":"40","author":[{"given":"Rino","family":"Ragno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Zwergel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Valente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Astolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Lambona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Proia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Giuliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott G.","family":"Franzblau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Fioravanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonello","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"key":"794_CR1","unstructured":"WHO Global tuberculosis report. Accessed 29 May 2021. http:\/\/www.who.int\/tb\/publications\/global_report\/en\/"},{"key":"794_CR2","doi-asserted-by":"crossref","unstructured":"Mourenza A, Gil JA, Mateos LM, Letek M (2020) Novel treatments against Mycobacterium tuberculosis based on drug repurposing. Antibiot (Basel) 9(9)","DOI":"10.3390\/antibiotics9090550"},{"issue":"1","key":"794_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1164\/rccm.202410-2096ST","volume":"211","author":"JJ Saukkonen","year":"2025","unstructured":"Saukkonen JJ, Duarte R, Munsiff SS, Winston CA, Mammen MJ, Abubakar I, Acu\u00f1a-Villaordu\u00f1a C, Barry PM, Bastos ML, Carr W, Chami H, Chen LL, Chorba T, Daley CL, Garcia-Prats AJ, Holland K, Konstantinidis I, Lipman M, Battista Migliori G, Parvez FM, Shapiro AE, Sotgiu G, Starke JR, Starks AM, Thakore S, Wang SH, Wortham JM, Nahid P (2025) Updates on the treatment of drug-susceptible and drug-resistant tuberculosis: an official ATS\/CDC\/ERS\/IDSA clinical practice guideline. Am J Respir Crit Care Med 211(1):15\u201333","journal-title":"Am J Respir Crit Care Med"},{"key":"794_CR4","doi-asserted-by":"crossref","unstructured":"Mitnick CD, Shin SS, Seung KJ, Rich ML, Atwood SS, Furin JJ, Fitzmaurice GM, Alcantara Viru FA, Appleton SC, Bayona JN, Bonilla CA, Chalco K, Choi S, Franke MF, Fraser HS, Guerra D, Hurtado RM, Jazayeri D, Joseph K, Llaro K, Mestanza L, Mukherjee JS, Munoz M, Palacios E, Sanchez E, Sloutsky A, Becerra MC (2008) Comprehensive treatment of extensively drug-resistant tuberculosis. N Engl J Med 359(6):563\u2009\u2013\u200974","DOI":"10.1056\/NEJMoa0800106"},{"key":"794_CR5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.ejmech.2018.03.020","volume":"150","author":"A Campanico","year":"2018","unstructured":"Campanico A, Moreira R, Lopes F (2018) Drug discovery in tuberculosis. New drug targets and antimycobacterial agents. Eur J Med Chem 150:525\u2013545","journal-title":"Eur J Med Chem"},{"key":"794_CR6","unstructured":"Pipeline Working Group for New TB Drugs. Accessed 20 Sep 2020. https:\/\/www.newtbdrugs.org\/pipeline\/clinical"},{"issue":"6","key":"794_CR7","doi-asserted-by":"publisher","first-page":"849","DOI":"10.2217\/fmb.10.50","volume":"5","author":"A Matteelli","year":"2010","unstructured":"Matteelli A, Carvalho AC, Dooley KE, Kritski A (2010) TMC207: the first compound of a new class of potent anti-tuberculosis drugs. Future Microbiol 5(6):849\u2013858","journal-title":"Future Microbiol"},{"issue":"1","key":"794_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/2229-516X.112228","volume":"3","author":"R Mahajan","year":"2013","unstructured":"Mahajan R (2013) Bedaquiline: First FDA-approved tuberculosis drug in 40 years. Int J Appl Basic Med Res 3(1):1\u20132","journal-title":"Int J Appl Basic Med Res"},{"key":"794_CR9","first-page":"677","volume":"9","author":"JD Szumowski","year":"2015","unstructured":"Szumowski JD, Lynch JB (2015) Profile of delamanid for the treatment of multidrug-resistant tuberculosis. Drug Des Devel Ther 9:677\u2013682","journal-title":"Drug Des Devel Ther"},{"issue":"9","key":"794_CR10","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s40265-014-0241-5","volume":"74","author":"NJ Ryan","year":"2014","unstructured":"Ryan NJ, Lo JH (2014) Delamanid: first global approval. Drugs 74(9):1041\u20131045","journal-title":"Drugs"},{"issue":"1","key":"794_CR11","doi-asserted-by":"publisher","first-page":"5084","DOI":"10.1038\/s41598-018-23110-1","volume":"8","author":"R Baptista","year":"2018","unstructured":"Baptista R, Fazakerley DM, Beckmann M, Baillie L, Mur LAJ (2018) Untargeted metabolomics reveals a new mode of action of pretomanid (PA-824). Sci Rep 8(1):5084","journal-title":"Sci Rep"},{"issue":"1","key":"794_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cmi.2021.08.007","volume":"28","author":"T Gils","year":"2022","unstructured":"Gils T, Lynen L, de Jong BC, Van Deun A, Decroo T (2022) Pretomanid for tuberculosis: a systematic review. Clin Microbiol Infect 28(1):31\u201342","journal-title":"Clin Microbiol Infect"},{"key":"794_CR13","doi-asserted-by":"crossref","unstructured":"Sarathy JP, Gruber G, Dick T (2019) Re-understanding the mechanisms of action of the anti-mycobacterial drug bedaquiline. Antibiot (Basel) 8(4)","DOI":"10.3390\/antibiotics8040261"},{"issue":"1","key":"794_CR14","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/btm2.10106","volume":"4","author":"S Nath","year":"2019","unstructured":"Nath S (2019) Interpretation of the mechanism of action of antituberculosis drug bedaquiline based on a novel two-ion theory of energy coupling in ATP synthesis. Bioeng Transl Med 4(1):164\u2013170","journal-title":"Bioeng Transl Med"},{"issue":"2","key":"794_CR15","first-page":"E143","volume":"61","author":"E Armocida","year":"2020","unstructured":"Armocida E, Martini M (2020) Tuberculosis: a timeless challenge for medicine. J Prev Med Hyg 61(2):E143\u2013E147","journal-title":"J Prev Med Hyg"},{"key":"794_CR16","doi-asserted-by":"crossref","unstructured":"Kovar O, Kufa M, Finger V, Soukup O, Kratky M, Torruellas C, Roh J, Korabecny J (2025) Scaffold hopping in tuberculosis drug discovery: principles, applications, and case studies. J Med Chem","DOI":"10.1021\/acs.jmedchem.5c01100"},{"issue":"5","key":"794_CR17","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/cbdd.13934","volume":"98","author":"A Kumar","year":"2021","unstructured":"Kumar A, Karkara BB, Panda G (2021) Novel candidates in the clinical development pipeline for TB drug development and their synthetic approaches. Chem Biol Drug Des 98(5):787\u2013827","journal-title":"Chem Biol Drug Des"},{"issue":"3","key":"794_CR18","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2174\/157340607780620626","volume":"3","author":"M Protopopova","year":"2007","unstructured":"Protopopova M, Bogatcheva E, Nikonenko B, Hundert S, Einck L, Nacy CA (2007) In search of new cures for tuberculosis. Med Chem 3(3):301\u2013316","journal-title":"Med Chem"},{"key":"794_CR19","doi-asserted-by":"crossref","unstructured":"Melly G, Purdy GE (2019) MmpL proteins in physiology and pathogenesis of M. tuberculosis. Microorganisms 7 (3)","DOI":"10.3390\/microorganisms7030070"},{"issue":"2","key":"794_CR20","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/S1472-9792(08)70015-5","volume":"88","author":"LL-3858","year":"2008","unstructured":"LL-3858 (2008) Tuberculosis 88(2):126","journal-title":"Tuberculosis"},{"key":"794_CR21","unstructured":"Arora SK, Sinha N, Jain S, Upadhayaya RS, Tyagi OD, Nalam V, Chauhan YK (2006) Preparation of [2-methyl-5-phenyl-3-(piperazin-1-ylmethyl)] pyrrole derivatives. WO2006109323A1"},{"issue":"3","key":"794_CR22","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1128\/AAC.00749-08","volume":"53","author":"J van den Boogaard","year":"2009","unstructured":"van den Boogaard J, Kibiki GS, Kisanga ER, Boeree MJ, Aarnoutse RE (2009) New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development. Antimicrob Agents Chemother 53(3):849\u2013862","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"794_CR23","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1016\/j.bmcl.2012.02.091","volume":"22","author":"AV Ramani","year":"2012","unstructured":"Ramani AV, Monika A, Indira VL, Karyavardhi G, Venkatesh J, Jeankumar VU, Manjashetty TH, Yogeeswari P, Sriram D (2012) Synthesis of highly potent novel anti-tubercular isoniazid analogues with preliminary pharmacokinetic evaluation. Bioorg Med Chem Lett 22(8):2764\u20132767","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"794_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1517\/13543784.14.1.93","volume":"14","author":"M N Alekshun","year":"2005","unstructured":"N Alekshun M (2005) 44th Interscience Conference on Antimicrobial Agents and Chemotherapy: an update on new antibiotics, novel non-antibacterial treatment modalities and critical issues in antibiotic resistance. Expert Opin Investig Drugs 14(1):93\u201399","journal-title":"Expert Opin Investig Drugs"},{"key":"794_CR25","volume-title":"Understanding tuberculosis\u2014new approaches to fighting against drug resistance","author":"R Kumar","year":"2012","unstructured":"Kumar R (2012) Chemotherapeutic strategies and targets against resistant TB. In: Cardona P-J (ed) Understanding tuberculosis\u2014new approaches to fighting against drug resistance. Rijeka, IntechOpen"},{"issue":"8","key":"794_CR26","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1021\/ja01062a035","volume":"86","author":"C Hansch","year":"1964","unstructured":"Hansch C, Fujita T (1964) p-\u03c3-\u03c0 analysis. A method for the correlation of biological activity and chemical structure. J Am Chem Soc 86(8):1616\u20131626","journal-title":"J Am Chem Soc"},{"issue":"4","key":"794_CR27","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1021\/jm00334a001","volume":"7","author":"SM Free","year":"1964","unstructured":"Free SM, Wilson JW (1964) A mathematical contribution to structure-activity studies. J Med Chem 7(4):395\u2013399","journal-title":"J Med Chem"},{"issue":"18","key":"794_CR28","doi-asserted-by":"publisher","first-page":"5959","DOI":"10.1021\/ja00226a005","volume":"110","author":"RD Cramer","year":"1988","unstructured":"Cramer RD, Patterson DE, Bunce JD (1988) Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 110(18):5959\u20135967","journal-title":"J Am Chem Soc"},{"issue":"14","key":"794_CR29","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1021\/jm00014a020","volume":"38","author":"AR Ortiz","year":"1995","unstructured":"Ortiz AR, Pisabarro MT, Gago F, Wade RC (1995) Prediction of drug binding affinities by comparative binding energy analysis. J Med Chem 38(14):2681\u20132691","journal-title":"J Med Chem"},{"issue":"1","key":"794_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1021\/ci00057a005","volume":"28","author":"D Weininger","year":"1988","unstructured":"Weininger D (1988) a chemical language and information system. 1. Introduction to methodology and encoding rules. J Chem Inf Comput Sci 28(1):31\u201336","journal-title":"J Chem Inf Comput Sci"},{"issue":"9","key":"794_CR31","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s10822-019-00231-x","volume":"33","author":"R Ragno","year":"2019","unstructured":"Ragno R (2019) www.3d-qsar.com: a web portal that brings 3-D QSAR to all electronic devices-the Py-CoMFA web application as tool to build models from pre-aligned datasets. J Comput Aided Mol Des 33(9):855\u2013864","journal-title":"J Comput Aided Mol Des"},{"key":"794_CR32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1752-153X-2-5","volume":"2","author":"NM O\u2019Boyle","year":"2008","unstructured":"O\u2019Boyle NM, Morley C, Hutchison GR (2008) Pybel: a Python wrapper for the OpenBabel cheminformatics toolkit. Chem Cent J 2:5","journal-title":"Chem Cent J"},{"key":"794_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR (2011) Open Babel: an open chemical toolbox. J Cheminform 3:33","journal-title":"J Cheminform"},{"issue":"5","key":"794_CR34","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1021\/ci2004658","volume":"52","author":"JP Ebejer","year":"2012","unstructured":"Ebejer JP, Morris GM, Deane CM (2012) Freely available conformer generation methods: how good are they? J Chem Inf Model 52(5):1146\u20131158","journal-title":"J Chem Inf Model"},{"issue":"7","key":"794_CR35","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1002\/jcc.21707","volume":"32","author":"CW Yap","year":"2011","unstructured":"Yap CW (2011) PaDEL-descriptor: an open source software to calculate molecular descriptors and fingerprints. J Comput Chem 32(7):1466\u20131474","journal-title":"J Comput Chem"},{"issue":"2","key":"794_CR36","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0169-7439(01)00155-1","volume":"58","author":"S Wold","year":"2001","unstructured":"Wold S, Sj\u00f6str\u00f6m M, Eriksson L (2001) PLS-regression: a basic tool of chemometrics. Chemometr Intell Lab Syst 58(2):109\u2013130","journal-title":"Chemometr Intell Lab Syst"},{"issue":"7","key":"794_CR37","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1021\/acs.jchemed.0c00117","volume":"97","author":"R Ragno","year":"2020","unstructured":"Ragno R, Esposito V, Di Mario M, Masiello S, Viscovo M, Cramer RD (2020) Teaching and learning computational drug design: student investigations of 3D quantitative structure-activity relationships through web applications. J Chem Educ 97(7):1922\u20131930","journal-title":"J Chem Educ"},{"issue":"3","key":"794_CR38","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.cell.2019.01.003","volume":"176","author":"B Zhang","year":"2019","unstructured":"Zhang B, Li J, Yang X, Wu L, Zhang J, Yang Y, Zhao Y, Zhang L, Yang X, Yang X, Cheng X, Liu Z, Jiang B, Jiang H, Guddat LW, Yang H, Rao Z (2019) Crystal structures of membrane transporter MmpL3, an Anti-TB Drug Target. Cell 176(3):636\u2013648 e13","journal-title":"Cell"},{"issue":"10","key":"794_CR39","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.str.2022.07.009","volume":"30","author":"T Hu","year":"2022","unstructured":"Hu T, Yang X, Liu F, Sun S, Xiong Z, Liang J, Yang X, Wang H, Yang X, Guddat LW, Yang H, Rao Z, Zhang B (2022) Structure-based design of anti-mycobacterial drug leads that target the mycolic acid transporter MmpL3. Structure 30(10):1395\u20131402 e4","journal-title":"Structure"},{"issue":"10","key":"794_CR40","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.str.2021.06.013","volume":"29","author":"O Adams","year":"2021","unstructured":"Adams O, Deme JC, Parker JL, Fowler PW, Lea SM, Newstead S (2021) Cryo-EM structure and resistance landscape of M. tuberculosis MmpL3: an emergent therapeutic target. Structure 29(10):1182\u20131191e4","journal-title":"Structure"},{"issue":"3","key":"794_CR41","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1021\/acs.jchemed.5b00404","volume":"93","author":"C Zardecki","year":"2016","unstructured":"Zardecki C, Dutta S, Goodsell DS, Voigt M, Burley SK (2016) RCSB protein data bank: a resource for chemical, biochemical, and structural explorations of large and small biomolecules. J Chem Educ 93(3):569\u2013575","journal-title":"J Chem Educ"},{"issue":"3","key":"794_CR42","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s10822-018-0096-z","volume":"32","author":"M Sabatino","year":"2018","unstructured":"Sabatino M, Rotili D, Patsilinakos A, Forgione M, Tomaselli D, Alby F, Arimondo PB, Mai A, Ragno R (2018) Disruptor of telomeric silencing 1-like (DOT1L): disclosing a new class of non-nucleoside inhibitors by means of ligand-based and structure-based approaches. J Comput Aided Mol Des 32(3):435\u2013458","journal-title":"J Comput Aided Mol Des"},{"issue":"7","key":"794_CR43","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s10822-022-00460-7","volume":"36","author":"E Proia","year":"2022","unstructured":"Proia E, Ragno A, Antonini L, Sabatino M, Mladenovic M, Capobianco R, Ragno R (2022) Ligand-based and structure-based studies to develop predictive models for SARS-CoV-2 main protease inhibitors through the 3d-qsar.com portal. J Comput Aided Mol Des 36(7):483\u2013505","journal-title":"J Comput Aided Mol Des"},{"issue":"13","key":"794_CR44","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE (2004) UCSF Chimera\u2014a visualization system for exploratory research and analysis. J Comput Chem 25(13):1605\u20131612","journal-title":"J Comput Chem"},{"issue":"6","key":"794_CR45","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1021\/acs.jmedchem.6b00031","volume":"59","author":"S Bhakta","year":"2016","unstructured":"Bhakta S, Scalacci N, Maitra A, Brown AK, Dasugari S, Evangelopoulos D, McHugh TD, Mortazavi PN, Twist A, Petricci E, Manetti F, Castagnolo D (2016) Design and Synthesis of 1-((1,5-Bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl)methyl)-4-methylpiperazine (BM212) and N-Adamantan-2-yl-N\u2032-((E)-3,7-dimethylocta-2,6-dienyl)ethane-1,2-diamine (SQ109) Pyrrole hybrid derivatives: discovery of potent antitubercular agents effective against multidrug-resistant mycobacteria. J Med Chem 59(6):2780\u20132793","journal-title":"J Med Chem"},{"issue":"15","key":"794_CR46","doi-asserted-by":"publisher","first-page":"5716","DOI":"10.1016\/j.bmc.2009.05.058","volume":"17","author":"D Castagnolo","year":"2009","unstructured":"Castagnolo D, Manetti F, Radi M, Bechi B, Pagano M, De Logu A, Meleddu R, Saddi M, Botta M (2009) Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: Part 2. Synthesis of rigid pyrazolones. Bioorg Med Chem 17(15):5716\u20135721","journal-title":"Bioorg Med Chem"},{"issue":"214","key":"794_CR47","doi-asserted-by":"publisher","first-page":"214ra168","DOI":"10.1126\/scitranslmed.3007355","volume":"5","author":"SP Rao","year":"2013","unstructured":"Rao SP, Lakshminarayana SB, Kondreddi RR, Herve M, Camacho LR, Bifani P, Kalapala SK, Jiricek J, Ma NL, Tan BH, Ng SH, Nanjundappa M, Ravindran S, Seah PG, Thayalan P, Lim SH, Lee BH, Goh A, Barnes WS, Chen Z, Gagaring K, Chatterjee AK, Pethe K, Kuhen K, Walker J, Feng G, Babu S, Zhang L, Blasco F, Beer D, Weaver M, Dartois V, Glynne R, Dick T, Smith PW, Diagana TT, Manjunatha UH (2013) Indolcarboxamide is a preclinical candidate for treating multidrug-resistant tuberculosis. Sci Transl Med 5(214):214ra168","journal-title":"Sci Transl Med"},{"issue":"19","key":"794_CR48","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1016\/j.bmcl.2018.08.026","volume":"28","author":"J Graham","year":"2018","unstructured":"Graham J, Wong CE, Day J, McFaddin E, Ochsner U, Hoang T, Young CL, Ribble W, DeGroote MA, Jarvis T, Sun X (2018) Discovery of benzothiazole amides as potent antimycobacterial agents. Bioorg Med Chem Lett 28(19):3177\u20133181","journal-title":"Bioorg Med Chem Lett"},{"key":"794_CR49","doi-asserted-by":"crossref","unstructured":"Remuinan MJ, Perez-Herran E, Rullas J, Alemparte C, Martinez-Hoyos M, Dow DJ, Afari J, Mehta N, Esquivias J, Jimenez E, Ortega-Muro F, Fraile-Gabaldon MT, Spivey VL, Loman NJ, Pallen MJ, Constantinidou C, Minick DJ, Cacho M, Rebollo-Lopez MJ, Gonzalez C, Sousa V, Angulo-Barturen I, Mendoza-Losana A, Barros D, Besra GS, Ballell L, Cammack N (2013) Tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide and N-benzyl-6\u2019,7\u2019-dihydrospiro[piperidine-4,4\u2019-thieno[3,2-c]pyran] analogues with bactericidal efficacy against Mycobacterium tuberculosis targeting MmpL3. PLoS One 8(4):e60933","DOI":"10.1371\/journal.pone.0060933"},{"issue":"D1","key":"794_CR50","doi-asserted-by":"publisher","first-page":"D1180","DOI":"10.1093\/nar\/gkad1004","volume":"52","author":"B Zdrazil","year":"2024","unstructured":"Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kiziloren T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR (2024) The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res 52(D1):D1180\u2013D1192","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"794_CR51","doi-asserted-by":"publisher","first-page":"D1516","DOI":"10.1093\/nar\/gkae1059","volume":"53","author":"S Kim","year":"2025","unstructured":"Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, Li Q, Shoemaker BA, Thiessen PA, Yu B, Zaslavsky L, Zhang J, Bolton EE (2025) PubChem 2025 update. Nucleic Acids Res 53(D1):D1516\u2013D1525","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"794_CR52","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1021\/acsmedchemlett.1c00431","volume":"13","author":"D Semenya","year":"2022","unstructured":"Semenya D, Touitou M, Ribeiro CM, Pavan FR, Pisano L, Singh V, Chibale K, Bano G, Toscani A, Manetti F, Gianibbi B, Castagnolo D (2022) Structural Rigidification of N-Aryl-pyrroles into indoles active against intracellular and drug-resistant mycobacteria. ACS Med Chem Lett 13(1):63\u201369","journal-title":"ACS Med Chem Lett"},{"key":"794_CR53","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, Blondel M, Prettenhofer P, Weiss R, Dubourg V, Vanderplas J, Passos A, Cournapeau D, Brucher M, Perrot M, Duchesnay E (2011) Scikit-learn: machine learning in Python. J Mach Learn Res 12:2825\u20132830","journal-title":"J Mach Learn Res"},{"issue":"6","key":"794_CR54","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1021\/ci6005646","volume":"47","author":"MJ Vainio","year":"2007","unstructured":"Vainio MJ, Johnson MS (2007) Generating conformer ensembles using a multiobjective genetic algorithm. J Chem Inf Model 47(6):2462\u20132474","journal-title":"J Chem Inf Model"},{"issue":"2","key":"794_CR55","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1021\/ci800315d","volume":"49","author":"MJ Vainio","year":"2009","unstructured":"Vainio MJ, Puranen JS, Johnson MS (2009) ShaEP: molecular overlay based on shape and electrostatic potential. J Chem Inf Model 49(2):492\u2013502","journal-title":"J Chem Inf Model"},{"key":"794_CR56","unstructured":"Landrum G (2016) RDKit: open-source cheminformatics software"},{"issue":"2","key":"794_CR57","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jmgm.2008.04.003","volume":"27","author":"J Taminau","year":"2008","unstructured":"Taminau J, Thijs G, De Winter H (2008) Pharao: pharmacophore alignment and optimization. J Mol Graph Model 27(2):161\u2013169","journal-title":"J Mol Graph Model"},{"issue":"11","key":"794_CR58","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1021\/j100011a016","volume":"99","author":"JA Grant","year":"1995","unstructured":"Grant JA, Pickup BT (1995) A Gaussian description of molecular shape. J Phys Chem 99(11):3503\u20133510","journal-title":"J Phys Chem"},{"issue":"10","key":"794_CR59","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1093\/bioinformatics\/btaa089","volume":"36","author":"C Mirabello","year":"2020","unstructured":"Mirabello C, Wallner B (2020) InterLig: improved ligand-based virtual screening using topologically independent structural alignments. Bioinformatics 36(10):3266\u20133267","journal-title":"Bioinformatics"},{"issue":"7","key":"794_CR60","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1021\/ci500006d","volume":"54","author":"T Kawabata","year":"2014","unstructured":"Kawabata T, Nakamura H (2014) 3D flexible alignment using 2D maximum common substructure: dependence of prediction accuracy on target-reference chemical similarity. J Chem Inf Model 54(7):1850\u20131863","journal-title":"J Chem Inf Model"},{"key":"794_CR61","first-page":"281","volume":"13","author":"J Bergstra","year":"2012","unstructured":"Bergstra J, Bengio Y (2012) Random search for hyper-parameter optimization. J Mach Learn Res 13:281\u2013305","journal-title":"J Mach Learn Res"},{"issue":"1","key":"794_CR62","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/pro.3235","volume":"27","author":"TD Goddard","year":"2018","unstructured":"Goddard TD, Huang CC, Meng EC, Pettersen EF, Couch GS, Morris JH, Ferrin TE (2018) UCSF ChimeraX: meeting modern challenges in visualization and analysis. Protein Sci 27(1):14\u201325","journal-title":"Protein Sci"},{"issue":"4","key":"794_CR63","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.chembiol.2012.03.006","volume":"19","author":"C Varela","year":"2012","unstructured":"Varela C, Rittmann D, Singh A, Krumbach K, Bhatt K, Eggeling L, Besra GS, Bhatt A (2012) MmpL genes are associated with mycolic acid metabolism in mycobacteria and corynebacteria. Chem Biol 19(4):498\u2013506","journal-title":"Chem Biol"},{"issue":"30","key":"794_CR64","doi-asserted-by":"publisher","first-page":"7993","DOI":"10.1073\/pnas.1700062114","volume":"114","author":"Z Xu","year":"2017","unstructured":"Xu Z, Meshcheryakov VA, Poce G, Chng SS (2017) MmpL3 is the flippase for mycolic acids in mycobacteria. Proc Natl Acad Sci USA 114(30):7993\u20137998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"794_CR65","doi-asserted-by":"crossref","unstructured":"Fay A, Czudnochowski N, Rock JM, Johnson JR, Krogan NJ, Rosenberg O, Glickman MS (2019) Two accessory proteins govern MmpL3 mycolic acid transport in mycobacteria. mBio 10(3)","DOI":"10.1128\/mBio.00850-19"},{"issue":"4","key":"794_CR66","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nchembio.794","volume":"8","author":"AE Grzegorzewicz","year":"2012","unstructured":"Grzegorzewicz AE, Pham H, Gundi VA, Scherman MS, North EJ, Hess T, Jones V, Gruppo V, Born SE, Kordulakova J, Chavadi SS, Morisseau C, Lenaerts AJ, Lee RE, McNeil MR, Jackson M (2012) Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane. Nat Chem Biol 8(4):334\u2013341","journal-title":"Nat Chem Biol"},{"key":"794_CR67","doi-asserted-by":"crossref","unstructured":"Domenech P, Reed MB, Barry CE 3 (2005) Contribution of the Mycobacterium tuberculosis MmpL protein family to virulence and drug resistance. Infect Immun 73(6):3492\u20133501","DOI":"10.1128\/IAI.73.6.3492-3501.2005"},{"issue":"16","key":"794_CR68","doi-asserted-by":"publisher","first-page":"4426","DOI":"10.1016\/j.jmb.2020.05.019","volume":"432","author":"X Yang","year":"2020","unstructured":"Yang X, Hu T, Yang X, Xu W, Yang H, Guddat LW, Zhang B, Rao Z (2020) Structural Basis for the Inhibition of Mycobacterial MmpL3 by NITD-349 and SPIRO. J Mol Biol 432(16):4426\u20134434","journal-title":"J Mol Biol"},{"issue":"5","key":"794_CR69","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1021\/ci050413p","volume":"46","author":"P Gedeck","year":"2006","unstructured":"Gedeck P, Rohde B, Bartels C (2006) QSAR\u2013how good is it in practice? Comparison of descriptor sets on an unbiased cross section of corporate data sets. J Chem Inf Model 46(5):1924\u20131936","journal-title":"J Chem Inf Model"},{"issue":"1","key":"794_CR70","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1021\/jm0493921","volume":"48","author":"R Ragno","year":"2005","unstructured":"Ragno R, Frasca S, Manetti F, Brizzi A, Massa S (2005) HIV-reverse transcriptase inhibition: inclusion of ligand-induced fit by cross-docking studies. J Med Chem 48(1):200\u2013212","journal-title":"J Med Chem"},{"key":"794_CR71","doi-asserted-by":"crossref","unstructured":"Quiroga R, Villarreal MA (2016) Vinardo: a scoring function based on autodock vina improves scoring, docking, and virtual screening. PLoS One 11 (5):e0155183","DOI":"10.1371\/journal.pone.0155183"},{"key":"794_CR72","doi-asserted-by":"crossref","unstructured":"Korb O, St\u00fctzle T, Exner TE, In (2006) PLANTS: application of ant colony optimization to structure-based drug design, ant colony optimization and swarm intelligence. Berlin, Heidelberg","DOI":"10.1007\/11839088_22"},{"key":"794_CR73","unstructured":"Dorigo M, Gambardella LM, Birattari M, Martinoli A, Poli R, St\u00fctzle T (eds) (2006) Springer, Berlin, Heidelberg, pp 247\u2013258"},{"issue":"8","key":"794_CR74","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1021\/ci300604z","volume":"53","author":"DR Koes","year":"2013","unstructured":"Koes DR, Baumgartner MP, Camacho CJ (2013) Lessons learned in empirical scoring with smina from the CSAR 2011 benchmarking exercise. J Chem Inf Model 53(8):1893\u20131904","journal-title":"J Chem Inf Model"},{"issue":"1","key":"794_CR75","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1021\/ci800298z","volume":"49","author":"O Korb","year":"2009","unstructured":"Korb O, Stutzle T, Exner TE (2009) Empirical scoring functions for advanced protein-ligand docking with PLANTS. J Chem Inf Model 49(1):84\u201396","journal-title":"J Chem Inf Model"},{"key":"794_CR76","doi-asserted-by":"crossref","unstructured":"Case DA, Aktulga HM, Belfon K, Cerutti DS, Cisneros GA, Cruzeiro VWD, Forouzesh N, Giese TJ, G\u00f6tz AW, Gohlke H, Izadi S, Kasavajhala K, Kaymak MC, King E, Kurtzman T, Lee T-S, Li P, Liu J, Luchko T, Luo R, Manathunga M, Machado MR, Nguyen HM, O\u2019Hearn KA, Onufriev AV, Pan F, Pantano S, Qi R, Rahnamoun A, Risheh A, Schott-Verdugo S, Shajan A, Swails J, Wang J, Wei H, Wu X, Wu Y, Zhang S, Zhao S, Zhu Q, Cheatham III TE, Roe DR, Roitberg A, Simmerling C, York DM, Nagan MC, Merz Jr KM (2023) AmberTools. J Chem Inf Model 63(20):6183\u20136191","DOI":"10.1021\/acs.jcim.3c01153"},{"issue":"8","key":"794_CR77","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1021\/ci300160y","volume":"52","author":"L Silvestri","year":"2012","unstructured":"Silvestri L, Ballante F, Mai A, Marshall GR, Ragno R (2012) Histone deacetylase inhibitors: structure-based modeling and isoform-selectivity prediction. J Chem Inf Model 52(8):2215\u20132235","journal-title":"J Chem Inf Model"},{"issue":"10","key":"794_CR78","doi-asserted-by":"publisher","first-page":"4799","DOI":"10.1038\/s41596-021-00597-z","volume":"16","author":"BJ Bender","year":"2021","unstructured":"Bender BJ, Gahbauer S, Luttens A, Lyu J, Webb CM, Stein RM, Fink EA, Balius TE, Carlsson J, Irwin JJ, Shoichet BK (2021) A practical guide to large-scale docking. Nat Protoc 16(10):4799\u20134832","journal-title":"Nat Protoc"},{"key":"794_CR79","doi-asserted-by":"crossref","unstructured":"Rueda M, Abagyan R (2016) Best practices in docking and activity prediction. bioRxiv 039446","DOI":"10.1101\/039446"},{"issue":"5","key":"794_CR80","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1128\/AAC.41.5.1004","volume":"41","author":"L Collins","year":"1997","unstructured":"Collins L, Franzblau SG (1997) Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob Agents Chemother 41(5):1004\u20131009","journal-title":"Antimicrob Agents Chemother"},{"key":"794_CR81","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/978-1-4939-2450-9_17","volume":"1285","author":"S Cho","year":"2015","unstructured":"Cho S, Lee HS, Franzblau S (2015) Microplate alamar blue assay (MABA) and low oxygen recovery assay (LORA) for Mycobacterium tuberculosis. Methods Mol Biol 1285:281\u2013292","journal-title":"Methods Mol Biol"},{"key":"794_CR82","doi-asserted-by":"publisher","first-page":"105137","DOI":"10.1016\/j.tiv.2021.105137","volume":"74","author":"A Nandikolla","year":"2021","unstructured":"Nandikolla A, Srinivasarao S, Khetmalis YM, Kumar BK, Murugesan S, Shetye G, Ma R, Franzblau SG, Sekhar K (2021) Design, synthesis and biological evaluation of novel 1,2,3-triazole analogues of Imidazo-[1,2-a]-pyridine-3-carboxamide against Mycobacterium tuberculosis. Toxicol Vitro 74:105137","journal-title":"Toxicol Vitro"},{"key":"794_CR83","unstructured":"White EL, Maddox C, Nebane NM, Tower NA, McKellip S, Manuvakhova A, Reddy L, Sosa M, Rasmussen L, Whig K, Ananthan S, Lun S, Bishai W, Weiner WS, Schoenen F, Dutta A, Aube J (2010) Discovery and development of highly potent inhibitors of Mycobacterium tuberculosis growth in vitro. In Probe Reports from the NIH Molecular Libraries Program, Bethesda (MD)"},{"issue":"9","key":"794_CR84","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s11095-018-2439-9","volume":"35","author":"AL Perryman","year":"2018","unstructured":"Perryman AL, Patel JS, Russo R, Singleton E, Connell N, Ekins S, Freundlich JS (2018) Naive Bayesian models for vero cell cytotoxicity. Pharm Res 35(9):170","journal-title":"Pharm Res"},{"key":"794_CR85","doi-asserted-by":"publisher","first-page":"102654","DOI":"10.1016\/j.tube.2025.102654","volume":"154","author":"M Xu","year":"2025","unstructured":"Xu M, Zhang L, Wang B, Fu L, Guo S, Chen X, Zhang W, Li G, Li P, Huang H, Lu Y (2025) In vitro and in vivo activities of a novel benzothiopyranone candidate NTB-3119\u00a0M against Mycobacterium tuberculosis. Tuberculosis (Edinb) 154:102654","journal-title":"Tuberculosis (Edinb)"},{"key":"794_CR86","doi-asserted-by":"publisher","first-page":"130447","DOI":"10.1016\/j.bmcl.2025.130447","volume":"131","author":"OK Onajole","year":"2026","unstructured":"Onajole OK, Lun S, Kishore DR, Savic A, Morales A, Guzman A, Schmidt E, Lazzara A, Fajardo G, Jamieson DP, Ayitou AJ, Bishai WR (2026) Exploration of imidazothiazole and imidazopyrimidine carboxamides for enhanced antitubercular activity. Bioorg Med Chem Lett 131:130447","journal-title":"Bioorg Med Chem Lett"},{"key":"794_CR87","doi-asserted-by":"publisher","first-page":"e4683","DOI":"10.55905\/cuadv16n6-211","volume":"16","author":"A Oliveira","year":"2024","unstructured":"Oliveira A, Sampiron E, Meneguello J, Ieque A, Caleffi-Ferracioli K, Cardoso R, Vandresen F, Scodro R (2024) Cytotoxicity and activity of thiosemicarbazones and semicarbazones in Mycobacterium tuberculosis: a systematic review. Cuad de Educaci\u00f3n y Desarrollo 16:e4683","journal-title":"Cuad de Educaci\u00f3n y Desarrollo"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00794-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-026-00794-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00794-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T07:02:25Z","timestamp":1775458945000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-026-00794-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["794"],"URL":"https:\/\/doi.org\/10.1007\/s10822-026-00794-6","relation":{},"ISSN":["1573-4951"],"issn-type":[{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]},"assertion":[{"value":"4 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"92"}}